In summary, our integrated in vitro and in vivo studies identify the critical role of Sig1R in limiting EC inflammation and permeability associated with ALI and support the idea that targeting Sig1R for its activation could prove a viable therapeutic strategy against ALI in sepsis. This evidence concerns the gene SIGMAR1 and acute respiratory distress syndrome.